Arlene A. Forastiere

Professor

1981 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Arlene A. Forastiere is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles
Head and Neck Neoplasms Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Laryngeal Neoplasms Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2019

GEAMP, a novel gastroesophageal junction carcinoma cell line derived from a malignant pleural effusion

Zhang, W., Williams, T. A., Bhagwath, A. S., Hiermann, J. S., Peacock, C. D., Watkins, D. N., Ding, P., Park, J. Y., Montgomery, E. A., Forastiere, A. A., Jie, C., Cantarel, B. L., Pham, T. H. & Wang, D. H., Jan 1 2019, In : Laboratory Investigation.

Research output: Contribution to journalArticle

Malignant Pleural Effusion
Esophagogastric Junction
Carcinoma
Cell Line
Neoplasms

Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Argiris, A., Li, S., Savvides, P., Ohr, J. P., Gilbert, J., Levine, M. A., Chakravarti, A., Haigentz, M., Saba, N. F., Ikpeazu, C. V., Schneider, C. J., Pinto, H. A., Forastiere, A. A. & Burtness, B., Dec 1 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 34, p. 3266-3274 9 p.

Research output: Contribution to journalArticle

Head and Neck Neoplasms
Drug Therapy
Platinum
Bevacizumab
Disease-Free Survival

Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature

Bossi, P., Alfieri, S., Strojan, P., Takes, R. P., López, F., Mäkitie, A., Saba, N. F., Rodrigo, J. P., Bradford, C., Suarez, C., Zafereo, M., Forastiere, A. A., Vermorken, J. B., Quer, M., Sanabria, A., Simo, R., de Bree, R., Rinaldo, A. & Ferlito, A., May 1 2019, In : Critical Reviews in Oncology/Hematology. 137, p. 84-91 8 p.

Research output: Contribution to journalReview article

Papillomaviridae
Therapeutics
Palliative Care
Immunotherapy
Caregivers

PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma

Eze, N., Lee, J. W., Yang, D. H., Zhu, F., Neumeister, V., Sandoval-Schaefer, T., Mehra, R., Ridge, J. A., Forastiere, A. A., Chung, C. H. & Burtness, B., Apr 1 2019, In : Oral Oncology. 91, p. 69-78 10 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinases
Epidermal Growth Factor Receptor
Cisplatin
Biomarkers
Placebos
Population
Clinical Trials
Therapeutics
Carboplatin
Cisplatin